Creo Medical Group PLCLSE Creo Medical Stock Report

Creo Medical Group Plc operates as a medical device company that focuses on surgical endoscopy. The company is headquartered in Chepstow, Monmouthshire/Sir Fynwy and currently employs 316 full-time employees. The company went IPO on 2016-12-09. The firm is focused on the research, development, and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The company has four technology families, which include Speedboat, SpydrBlade, MicroBlate, and SlypSeal. Speedboat is its flagship advanced energy device product with over 1,000 procedures performed using the device. Speedboat device technology is a device technology with bipolar surgical dissection blade in any form of surgery. Additionally, Speedboat integrates microwave technology allowing for precise control of bleeding during surgery. The firm's SpydrBlade device technology optimizes the power of its CROMA Platform, where advanced bipolar radiofrequency (RF) energy is used to cut tissue and precisely controlled microwave energy is used for the coagulation and sealing of tissue during surgery.